Titre : Tumeurs de la trachée

Tumeurs de la trachée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Fields
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de la trachée : Questions médicales les plus fréquentes", "headline": "Tumeurs de la trachée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de la trachée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie de la trachée", "url": "https://questionsmedicales.fr/mesh/D014133", "about": { "@type": "MedicalCondition", "name": "Maladie de la trachée", "code": { "@type": "MedicalCode", "code": "D014133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.907" } } }, "about": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée", "alternateName": "Tracheal Neoplasms", "code": { "@type": "MedicalCode", "code": "D014134", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "V D Parshin", "url": "https://questionsmedicales.fr/author/V%20D%20Parshin", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Rusakov", "url": "https://questionsmedicales.fr/author/M%20A%20Rusakov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M S Simonova", "url": "https://questionsmedicales.fr/author/M%20S%20Simonova", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Ursov", "url": "https://questionsmedicales.fr/author/M%20A%20Ursov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "Keiichi Morita", "url": "https://questionsmedicales.fr/author/Keiichi%20Morita", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Surgery, Kobe Children's Hospital, 1-6-7, Minatojima Minami-cho, Chuo-ku, Kobe, 650-0047, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Humphrey visual field made easy for residents.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39331457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/IJO.IJO_2519_23" } }, { "@type": "ScholarlyArticle", "name": "Detection of post-stroke visual field loss by quantification of the retrogeniculate visual pathway.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35640329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jns.2022.120297" } }, { "@type": "ScholarlyArticle", "name": "Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.", "datePublished": "2023-10-25", "url": "https://questionsmedicales.fr/article/37880406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45541-1" } }, { "@type": "ScholarlyArticle", "name": "Visual feedback in the lower visual field affects postural control during static standing.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35843008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gaitpost.2022.07.004" } }, { "@type": "ScholarlyArticle", "name": "Five-Year Visual Field Outcomes of the HORIZON Trial.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36813144", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.02.008" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Maladie de la trachée", "item": "https://questionsmedicales.fr/mesh/D014133" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de la trachée", "item": "https://questionsmedicales.fr/mesh/D014134" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de la trachée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de la trachée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de la trachée", "description": "Comment diagnostique-t-on une tumeur de la trachée ?\nQuels tests sont utilisés pour évaluer la fonction respiratoire ?\nLes examens d'imagerie sont-ils toujours nécessaires ?\nQuels symptômes peuvent indiquer une tumeur trachéale ?\nLa biopsie est-elle toujours requise pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de la trachée", "description": "Quels sont les symptômes courants des tumeurs trachéales ?\nLa voix peut-elle être affectée par une tumeur trachéale ?\nLes symptômes varient-ils selon le type de tumeur ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes peuvent-ils s'aggraver rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de la trachée", "description": "Peut-on prévenir les tumeurs de la trachée ?\nLe tabagisme est-il un facteur de risque ?\nLes expositions professionnelles peuvent-elles être un risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?\nUne alimentation saine peut-elle aider à prévenir ces tumeurs ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de la trachée", "description": "Quels traitements sont disponibles pour les tumeurs trachéales ?\nLa chirurgie est-elle toujours nécessaire ?\nLa radiothérapie est-elle efficace contre ces tumeurs ?\nQuels sont les effets secondaires des traitements ?\nPeut-on combiner plusieurs traitements ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de la trachée", "description": "Quelles complications peuvent survenir avec ces tumeurs ?\nLes tumeurs trachéales peuvent-elles se propager ?\nComment les complications affectent-elles le traitement ?\nLes infections sont-elles fréquentes avec ces tumeurs ?\nPeut-on prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de la trachée", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de tumeurs trachéales ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes infections respiratoires chroniques sont-elles un facteur de risque ?\nLes facteurs environnementaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Visual+Fields&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur de la trachée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (CT, IRM) et bronchoscopie pour biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la fonction respiratoire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire mesurent la capacité respiratoire et l'obstruction." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils toujours nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont essentiels pour visualiser la tumeur et son extension." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une tumeur trachéale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, difficultés respiratoires, et stridor peuvent alerter." } }, { "@type": "Question", "name": "La biopsie est-elle toujours requise pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la biopsie confirme la nature bénigne ou maligne de la tumeur." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs trachéales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Toux, dyspnée, stridor, douleur thoracique et hémoptysie sont fréquents." } }, { "@type": "Question", "name": "La voix peut-elle être affectée par une tumeur trachéale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une tumeur peut provoquer des changements de voix ou une dysphonie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer entre tumeurs bénignes et malignes." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même si la tumeur est petite ou cachée." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines tumeurs peuvent croître rapidement et aggraver les symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs de la trachée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais éviter le tabac aide." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer des tumeurs respiratoires." } }, { "@type": "Question", "name": "Les expositions professionnelles peuvent-elles être un risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des substances toxiques peut augmenter le risque de tumeurs." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs trachéales." } }, { "@type": "Question", "name": "Une alimentation saine peut-elle aider à prévenir ces tumeurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de cancer en général." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs trachéales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent la chirurgie, la radiothérapie et la chimiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, cela dépend de la taille et de la localisation de la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace contre ces tumeurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour réduire la taille des tumeurs malignes." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets peuvent inclure fatigue, irritation des voies respiratoires et nausées." } }, { "@type": "Question", "name": "Peut-on combiner plusieurs traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une approche multimodale est souvent utilisée pour optimiser les résultats." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces tumeurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent obstruction des voies respiratoires et infections." } }, { "@type": "Question", "name": "Les tumeurs trachéales peuvent-elles se propager ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent envahir les tissus voisins ou se propager à d'autres organes." } }, { "@type": "Question", "name": "Comment les complications affectent-elles le traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent compliquer le traitement et nécessiter des interventions supplémentaires." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes avec ces tumeurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections respiratoires peuvent survenir en raison de l'obstruction." } }, { "@type": "Question", "name": "Peut-on prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un suivi médical régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de tumeurs trachéales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les infections respiratoires chroniques sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent prédisposer à des tumeurs trachéales." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution de l'air et l'exposition à des irritants augmentent le risque." } } ] } ] }

Sources (10000 au total)

Humphrey visual field made easy for residents.

Visual field testing is an indispensable part of the assessment of glaucoma. Of paramount importance to both the practitioner and the perimetrist is the guidance on how to conduct the test to get the ... To simplify the basics of understanding single-field analysis of visual field tests by using the Humphrey perimeter.... The general principle and a brief overview of how the Humphrey visual field is conducted and the approach to interpreting the results of single field analysis in an easy-to-understand manner are prese... This educational video is an attempt to simplify the interpretation of Humphrey visual field single-field analysis with illustrations and video clips that would be useful to practicing ophthalmologist... https://youtu.be/x8iZLDR4XdY....

Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.

We investigated the relationship between foveal avascular zone (FAZ)-related parameters, assessed by optical coherence tomography angiography (OCT-A), and visual field (VF) progression in early-stage ...

Visual feedback in the lower visual field affects postural control during static standing.

The dorsal parietal visual system plays an important role in self-motion perception and spatial cognition. It also strongly responds to visual inputs from the lower visual field. Postural control is m... Do visual stimuli presented to the lower and upper visual fields affect postural control and sensory reweighting?... Twenty-nine healthy young adults participated in the study. Four conditions (full visual field, upper visual field, lower visual field, and no optic flow condition) were simulated in a VR environment ... Optic flow in the full and lower visual fields produced significantly smaller 95 % ellipse area and RMS of COP in the anterior-posterior direction compared to optic flow in the upper visual field. Furth... Visual feedback affects static postural control more when presented in the lower visual field compared to the upper visual field....

Five-Year Visual Field Outcomes of the HORIZON Trial.

To compare visual field (VF) progression between glaucoma patients receiving cataract surgery alone (CS) or with a Hydrus microstent (CS-HMS).... Post hoc analysis of VF data from the HORIZON multicenter randomized controlled trial.... A total of 556 patients with glaucoma and cataract were randomized 2:1 to either CS-HMS (369) or CS (187) and followed up for 5 years. VF was performed at 6 months and then every year after surgery. W... Data from 352 eyes in the CS-HMS arm and 165 in the CS arm were analyzed (2966 VFs). The mean RoP was -0.26 dB/y (95% credible interval -0.36, -0.16) for CS-HMS and -0.49 dB/y (95% credible interval -... CS-HMS has a significant effect on VF preservation in glaucoma patients compared with CS alone, reducing the proportion of fast progressors....

Effect of trabeculectomy on the rate of progression of visual field damage.

This study quantifies the effect of trabeculectomy on the rate of progression (RoP) of visual field (VF) damage utilising pre- and post-operative visual function as the outcome instead of surrogate ou... Clinical and VF data from 199 sequential patients who underwent trabeculectomy between 2015 and 2016 were extracted from the network of sites of Moorfields Eye Hospital NHS Foundation Trust. Of these,... We analysed 10 [9,12] VFs per subject (Median [Interquartile Range]). At surgery, the age was 67 [57, 72] years, mean deviation was -10.84 [-14.7, -5.6] dB and the IOP was 18 [15, 20] mmHg. One year a... Trabeculectomy leads to a significant reduction in the RoP of VF loss postoperatively....

A Consensus Statement on the Terminology for Automated Visual Field Abnormalities.

A multitude of terms have been used to describe automated visual field abnormalities. To date, there is no universally accepted system of definitions or guidelines. Variability among clinicians create... In phase one of the study, all neuro-ophthalmologists in Israel were asked to complete a survey in which they described the abnormalities in 10 selected automated visual field tests. In phase 2 of the... Twenty-six neuro-ophthalmologists participated in the initial survey. On average, there were 7.5 unique descriptions for each of the visual fields (SD 3.17), a description of only the location in 24.6... The study confirmed a great degree of variability in the use of terminology to describe automated visual field abnormalities. The creation of a consensus statement was associated with improved use of ...

Gaze tracker parameters have little association with visual field metrics of intrasession frontloaded SITA-Faster 24-2 visual field results.

To determine the usefulness of Humphrey Field Analyser (HFA) SITA-Faster 24-2 gaze tracker outputs on interpreting intra-visit visual field (VF) result pairs.... Analysis of 1380 right-left eye pairs and 1432 pairs of test 1-test 2 intrasession VF results of patients seen within a university-based glaucoma service was undertaken to understand gaze deviation di... There was no association of test order (right-left, test 1-test 2) with eye movements. There was a significant, but weak correlation between eye movements and age (r = 0.16). Correlations of eye movem... Eye movement parameters as currently reported by the HFA do not appear to be correlated with key sensitivity parameters when considering the repeatability of intrasession SITA-Faster 24-2 VF results. ...

Peripheral visual field loss and activities of daily living.

Peripheral visual field (VF) loss affects 13% of the population over 65. Its effect on activities of daily living and higher order visual processing is as important as it is inadequately understood. T... In this review, glaucoma and retrochiasmal cortical damage are utilized as examples of peripheral field loss which typically spare central vision and have patterns respecting the horizontal and vertic... Peripheral VF loss is an under-recognized cause of patient distress and disability. All peripheral field loss is not the same, differential patterns of loss affect parameters of activities of daily li...